NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National
Estimated value
£261.9m
Awarded value
£261.9m
Suppliers
1
Lots
1
Published
24 Jul 2025
Description
NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 Offer reference number: CM/PHR/24/5718 CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines - Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines - Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months.
Scope
- Reference
- CF-3097600D0O000000rwimUAA
- Total value
- £261,895,933 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Aug 2025 to 30 Aug 2027
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 18 Mar 2025, 1:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£261.9m
Award date
24 Jun 2025
Contract start
31 Aug 2025
Contract end
30 Aug 2027